India, Nov. 4 -- Medline, Inc. (MDLN), a provider of medical-surgical products and supply chain solutions, on Wednesday reported a sharp decline in third quarter profit attributed to the company, despite 10.4 percent increase in sales, compared to the prior year. The company further reaffirmed its fiscal 2026 adjusted EBITDA guidance.
Quarterly net income attributable to Medline was $195 million, as against $322 million year ago. The corresponding attributable earnings per share were $0.22 and $0.45, respectively.
The company recorded a one-time net income attributable to non-controlling interests of $123 million for the quarter.
Third quarter Adjusted EBITDA was $960 million, an increase of 11.8% from the prior year quarter.
Third quar...